All In MedTech

Device Trial Radar · NCT05820451

Impella Real-World Surveillance of Patients Using Sodium Bicarbonate

Last checked: Nov 20, 2026Latest source record: Sep 4, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

312

Actual

Start

Dec 15, 2022

Primary completion

Feb 22, 2024

Study completion Feb 22, 2024

Sponsor

Lead sponsor
Abiomed Inc.Public (JNJ)
Sponsor type
Industry
First posted
Apr 19, 2023

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The population enrolled in this study are all subjects who received an Impella in which a bicarbonate-based purge solution was used.

Conditions

  • Cardiogenic Shock
  • High Risk PCI

Interventions

  • Impella CP, 2.5, 5.0 and 5.5 with Sodium Bicarbonate used as purge solutionDevice

    US commercially approved Abiomed left sided hemodynamic support devices (Impella) will be included.

  • Impella RP with Sodium Bicarbonate used as purge solutionDevice

    US commercially approved Abiomed right sided hemodynamic support devices (Impella) will be included.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary Endpoint Left Sided ImpellaTime frame: From hospital admission until hospital discharge, average 5 days
  2. Primary Endpoint Right Sided ImpellaTime frame: From hospital admission until hospital discharge, average 5 days

Locations

20 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama

    Birmingham, Alabama

  • Pima Heart and Vascular (Tuscon Medical Center)

    Tucson, Arizona

  • Arkansas Heart Hospital

    Little Rock, Arkansas

17 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.